Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of Oral ASN51 in Healthy Subjects and Subjects With Alzheimer's Disease
- First Posted Date
- 2021-02-18
- Last Posted Date
- 2023-01-17
- Lead Sponsor
- Asceneuron Pty Ltd.
- Target Recruit Count
- 25
- Registration Number
- NCT04759365
- Locations
- 🇦🇺
Nucleus Network, Melbourne, Victoria, Australia
News
No news found